When the tariffs got announced and seeing how the market responded, my immediate thought was that we will soon see many dividend cuts across the board.Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial strategies and execute large-scale financings. He has also made significant efforts to institutionalize REIT framework in Latvia to boost the liquidity of pan-Baltic capital markets. Other policy-level work includes the development of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________. Commission file number: 001-37815 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) | Maryland ...

Global Medical REIT (GMRE) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Stephen Swett - PartnerJeffrey Busch - Chairman, President & CEOAlfonzo Leon - CIORobert Kiernan - CFO & TreasurerNone - ExecutiveJuan Sanabria - Managing DirectorGaurav Mehta - Managing Director Conference Call Participants Austin Wurschmidt - Senior Equity Research AnalystWesley Golladay - Senior Research AnalystJohn Massocca - Senior Research Analyst Operator Greetings, and welcome to the Global Medical REIT Fi ...

Global Medical REIT (GMRE) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Speaker0 Greetings, and welcome to the Global Medical REIT First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Steve Sweatt, Investor Relations. Thank you, sir. You may begin. Speaker1 Thank you. Good mor ...

Atrium Health – Winston-Salem, NC FIRST QUARTER 2025 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE TABLE OF CONTENTS Legent Hospital for Special Surgery – Plano, TX | Company Overview | 3 | | --- | --- | | Select Quarterly Financial Data | 6 | | Business Summary | 7 | | Acquisitions / Dispositions | 8 | | Portfolio Summary | 9 | | Key Tenants | 12 | | Debt and Hedging Summary | 13 | | Total Capitalization and Equity Summary | 15 | | Sustainability Summary | 16 | | Condensed Consolidated | 17 | ...

Exhibit 99.1 First Quarter 2025 and Other Highlights 1 · Net income attributable to common stockholders was $2.1 million, or $0.03 per diluted share, as compared to $0.8 million, or $0.01 per diluted share, in the comparable prior year period. · Funds from operations attributable to common stockholders and noncontrolling interest ("FFO") of $14.8 million, or $0.20 per share and unit, as compared to $14.9 million, or $0.21 per share and unit, in the comparable prior year period. · Adjusted funds from operati ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number: 001-37815 Global Medical REIT Inc. (Exact name of registrant as specified in its charter) | Maryland ...

Financial Data and Key Metrics Changes - At the end of Q4 2024, portfolio occupancy was 96.4% with a weighted average lease term of 5.6 years and a portfolio average rent coverage ratio of 4.5 times [8] - Net income attributable to common shareholders was $1.4 million, or $0.02 per share, compared to a net loss of $800,000, or $0.01 per share in Q4 2023 [29] - FFO attributable to common stockholders was $11.1 million, or $0.15 per share, down from $13.3 million, or $0.19 per share in Q4 2023 [29] - AFFO attributable to common stockholders was $15.8 million, or $0.22 per share, compared to $15.9 million in Q4 2023 [30] - Total revenues increased by approximately 6.7% to $35.2 million compared to the prior year [25] Business Line Data and Key Metrics Changes - The company completed the acquisition of a 15-property portfolio for $80.3 million, with an aggregate annualized base rent of $6.4 million, equating to an 8% cap rate [10][17] - In Q4, the company also entered into a purchase agreement for a five-property portfolio for $69.6 million at a 9% cap rate [11] Market Data and Key Metrics Changes - The transaction market for medical facilities continues to show promising momentum, with active engagement with physician groups and brokers to identify acquisition opportunities [16] - The company completed four property dispositions generating gross proceeds of $40.5 million, resulting in a gain of $5.8 million [12][22] Company Strategy and Development Direction - The company remains committed to maintaining a strong balance sheet through a strategic asset recycling program [12] - The joint venture with Heitman aims to target strong cash-on-cash returns and is expected to grow as Heitman raises more capital [42][44] - The company is focused on improving the quality of its portfolio by potentially selling off lower-quality assets [66][70] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate the current environment and execute its business strategy [38] - The CEO transition is seen as an opportunity to bring in fresh perspectives while maintaining a strong portfolio [14][51] - The company expects a 70% to 80% retention rate on lease expirations scheduled for 2025 [34] Other Important Information - The company recognized an impairment loss of $1.7 million in Q4 related to a facility in Derby, Kansas [28] - As of year-end 2024, the company had $651 million of total gross debt with a leverage ratio of 44.8% [35] Q&A Session Summary Question: Can you discuss the Heitman joint venture regarding target size and asset types? - The joint venture targets strong properties with decent lease terms, primarily single-tenant assets, and has about $50 million of equity available for this strategy [42][44] Question: What are the reasons for the CEO transition? - The CEO is stepping down due to age and a desire to reduce responsibilities, while still remaining active as chairman [50][51] Question: How much rent was collected from Prospect in Q4? - Prospect's exposure is around $150,000 per month, with the largest piece being the East Orange facility, which has been on a cash basis since late 2023 [56][82] Question: What is the expected CapEx for 2025? - The company expects capital expenditures of approximately $12 million to $14 million for 2025 [32][88] Question: Does the Heitman JV have a right of first refusal on new acquisitions? - No, the company retains the right to pursue acquisitions independently of the joint venture [106]

Atrium Health – Winston-Salem, NC FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE TABLE OF CONTENTS Legent Hospital for Special Surgery – Plano, TX | Company Overview | 3 | | --- | --- | | Select Quarterly Financial Data | 6 | | Business Summary | 7 | | Acquisitions / Dispositions | 8 | | Portfolio Summary | 9 | | Key Tenants | 12 | | Debt and Hedging Summary | 13 | | Total Capitalization and Equity | 15 | | Summary | | | Sustainability Summary | 16 | | Condensed Consolidated ...

Financial Performance - Net income attributable to common stockholders for Q4 2024 was $1.4 million, or $0.02 per diluted share, compared to a net loss of $0.8 million, or $0.01 per diluted share in Q4 2023[5]. - Total revenue for Q4 2024 was $35,157, an increase of 6.3% compared to $32,962 in Q4 2023[47]. - Net income for the twelve months ended December 31, 2024, was $6,692, a decrease of 69.2% from $21,734 in 2023[49]. - The company reported a gain on the sale of investment properties of $5,765 in Q4 2024, compared to no gain in Q4 2023[49]. - Adjusted EBITDAre for Q4 2024 was $25,095, an increase of 4.1% compared to $24,110 in Q4 2023[51]. Funds from Operations - Funds from Operations (FFO) for Q4 2024 was $11.1 million, or $0.15 per share, down from $13.3 million, or $0.19 per share in the prior year[11]. - Funds from Operations (FFO) attributable to common stockholders for Q4 2024 was $11,051, down from $13,307 in Q4 2023, representing a decrease of 16.9%[49]. - Adjusted Funds from Operations (AFFO) for the full year 2024 was $15.8 million, or $0.22 per share, compared to $15.9 million, or $0.23 per share in 2023[7]. - The company provided 2025 AFFO guidance of $0.89 to $0.93 per share[23]. Acquisitions and Investments - The company completed the acquisition of a 15-property portfolio for $80.3 million, with an annualized base rent of $6.4 million[12]. - The company entered into a joint venture with Heitman, generating $35.2 million in gross proceeds from the sale of two assets[15]. Portfolio and Occupancy - The portfolio leased occupancy was 96.4% as of December 31, 2024, with an annualized base rent of $110 million[17]. - The annualized base rent methodology produces an annualized amount as of a point in time but does not account for future contractual rental rate increases, leasing activity, or lease expirations[38]. Debt and Equity - Total debt outstanding as of December 31, 2024, was $646.1 million, with a leverage ratio of 44.8%[19]. - The company’s total liabilities increased to $700,570,000 in 2024 from $661,886,000 in 2023[42]. - The company’s total equity decreased to $555,916,000 in 2024 from $605,814,000 in 2023[42]. - The company raised $12 million through the issuance of 1.2 million shares at an average price of $9.95 per share during 2024[20]. Cash and Dividends - A cash dividend of $0.21 per share was declared for Q1 2025, payable on April 9, 2025[21]. - Cash and cash equivalents increased to $6,815,000 in 2024 from $1,278,000 in 2023[42]. Other Financial Metrics - The company's accumulated deficit increased to $(293,736,000) in 2024 from $(238,984,000) in 2023[42]. - The weighted average shares outstanding for basic and diluted shares increased to 66,838 in Q4 2024 from 65,565 in Q4 2023[49]. - The company incurred transaction expenses of $155 in Q4 2024, compared to $44 in Q4 2023[49].